Compare Illumina, Inc. (ILMN) vs SoundHound AI Inc (SOUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs SoundHound AI Inc — how do they compare? Illumina, Inc. trades at $191.6 (market cap $27.94B), while SoundHound AI Inc trades at $6.46 (market cap $2.75B). The key difference: Illumina, Inc. is far larger — about 10.2× SoundHound AI Inc's market cap, and Illumina, Inc. is trading nearer its 52-week high, SoundHound AI Inc nearer its low. Which is the better fit depends on your goals.
| ILMN | SOUN | |
|---|---|---|
Market Cap | $27.94B | $2.75B |
Sector | Health | Technology |
52-Week High | $194.33 | $21.40 |
52-Week Low | $91.00 | $5.90 |
Enterprise Value | $29.33B | $2.54B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
SoundHound AI (SOUN) trades at $6.31, down 37% year-to-date amid concerns over persistent losses and cash burn despite 52% revenue growth in 2025. The stock shows a bearish technical trend with neutral oscillators, while fundamentals reveal a negative net income margin of -91.84% and high valuation multiples. Recent positive developments include being named a Leader in Gartner's Magic Quadrant for Conversational AI Platforms (GlobeNewsWire, July 13, 2026) and beating EPS estimates in three consecutive quarters.
The outlook remains speculative with significant upside potential based on a $13.00 analyst consensus price target, but high execution risks and cash burn pose threats. Investment opportunity hinges on the company's ability to monetize its AI platform expansion and achieve profitability, while risks include competitive pressures and reliance on financing to cover operational losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About SoundHound AI Inc
SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →
